Quantcast

Industry news that matters to you.  Learn more

Minomic to Register MiStat ELISA Prostate Cancer Test for CE Mark Approval

Australian biotechnology company Minomic International Limited will register its MiStat(TM) ELISA prostate cancer test for CE Mark approval in the latter part of 2014.

Minomic to Commence Two US Trials of New Prostate Cancer Screening Technology, MiStat

Private Australian biotechnology company Minomic International Ltd will launch two overseas trials of its MiStatâ„¢ prostate cancer screening test, following an agreement with the prestigious CUSP Group, LLC a Uro-Oncology Trials Management Organisation in the United States.